You Dingyun, Zhao Hongbo, Wang Yan, Jiao Yang, Lu Minnan, Yan Shan
Kunming Medical University, Kunming City, Yunnan Province 650500, China.
Institute of Molecular and Clinical Medicine, Kunming City, Yunnan Province 650500, China.
Mol Cells. 2016 Sep;39(9):663-8. doi: 10.14348/molcells.2016.2267. Epub 2016 Sep 23.
The oncogene nuclear receptor coactivator amplified in breast cancer 1 (AIB1) is a transcriptional coactivator, which is overexpressed in various types of human cancers, including breast cancer. However, the molecular mechanisms regulating AIB1 function remain largely unknown. In this study, we present evidence demonstrating that AIB1 is acetylated by MOF in human breast cancer cells. Moreover, we also found that the acetylation of AIB1 enhances its function in promoting breast cancer cell proliferation. We further showed that the acetylation of AIB1 is required for its recruitment to E2F1 target genes by E2F1. More importantly, we found that the acetylation levels of AIB1 are greatly elevated in human breast cancer cells compared with that in non-cancerous cells. Collectively, our results shed light on the molecular mechanisms that regulate AIB1 function in breast cancer.
乳腺癌中扩增的致癌基因核受体辅激活因子1(AIB1)是一种转录辅激活因子,在包括乳腺癌在内的多种人类癌症中过表达。然而,调节AIB1功能的分子机制仍 largely未知。在本研究中,我们提供证据表明AIB1在人乳腺癌细胞中被MOF乙酰化。此外,我们还发现AIB1的乙酰化增强了其促进乳腺癌细胞增殖的功能。我们进一步表明,AIB1的乙酰化是其被E2F1招募至E2F1靶基因所必需的。更重要的是,我们发现与非癌细胞相比,人乳腺癌细胞中AIB1的乙酰化水平大大升高。总体而言,我们的结果揭示了调节AIB1在乳腺癌中功能的分子机制。